Detalhe da pesquisa
1.
[Febrile cholestatic jaundice as an initial manifestation of Hodgkin's disease]. / Ictericia febril colestásica como forma de presentación de linfoma de Hodgkin.
Medicina (B Aires);
74(1): 60-1, 2014.
Artigo
em Espanhol
| MEDLINE
| ID: mdl-24561844
2.
[Early use of tocilizumab in hospitalized patients with severe and critical COVID-19 in the Province of Buenos Aires: a multicentric study]. / Utilización precoz de tocilizumab en pacientes internados con COVID-19 grave y crítica: un estudio multicéntrico en la Provincia de Buenos Aires.
Medicina (B Aires);
83(2): 190-201, 2023.
Artigo
em Espanhol
| MEDLINE
| ID: mdl-37094187
3.
Protection of homologous and heterologous boosters after primary schemes of rAd26-rAd5, ChAdOx1 nCoV-19 and BBIBP-CorV during the omicron outbreak in adults of 50 years and older in Argentina: a test-negative case-control study.
Lancet Reg Health Am;
27: 100607, 2023 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37808936
4.
Effectiveness of BBIBP-CorV, BNT162b2 and mRNA-1273 vaccines against hospitalisations among children and adolescents during the Omicron outbreak in Argentina: A retrospective cohort study.
Lancet Reg Health Am;
13: 100316, 2022 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35872665
5.
Timing of convalescent plasma administration and 28-day mortality in COVID-19 pneumonia.
J Investig Med;
70(5): 1258-1264, 2022 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35135872
6.
Immune Response to SARS-CoV-2 Third Vaccine in Patients With Rheumatoid Arthritis Who Had No Seroconversion After Primary 2-Dose Regimen With Inactivated or Vector-Based Vaccines.
J Rheumatol;
49(12): 1385-1389, 2022 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36182107
7.
Immunogenicity and reactogenicity of heterologous immunization against SARS CoV-2 using Sputnik V, ChAdOx1-S, BBIBP-CorV, Ad5-nCoV, and mRNA-1273.
Cell Rep Med;
3(8): 100706, 2022 08 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35926505
8.
Estimating COVID-19 cases and outbreaks on-stream through phone calls.
R Soc Open Sci;
8(3): 202312, 2021 Mar 17.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33959370
9.
Effectiveness of the first component of Gam-COVID-Vac (Sputnik V) on reduction of SARS-CoV-2 confirmed infections, hospitalisations and mortality in patients aged 60-79: a retrospective cohort study in Argentina.
EClinicalMedicine;
40: 101126, 2021 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34541480
10.
Risk factors for COVID-19 mortality: The effect of convalescent plasma administration.
PLoS One;
16(4): e0250386, 2021.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33914780
11.
Sputnik V vaccine elicits seroconversion and neutralizing capacity to SARS-CoV-2 after a single dose.
Cell Rep Med;
2(8): 100359, 2021 08 17.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34308389
12.
Utilización precoz de tocilizumab en pacientes internados con COVID-19 grave y crítica: un estudio multicéntrico en la Provincia de Buenos Aires / Early use of tocilizumab in hospitalized patients with severe and critical COVID-19 in the Province of Buenos Aires: a multicentric study
Medicina (B.Aires);
83(2): 190-201, jun. 2023. graf
Artigo
em Espanhol
|
LILACS-Express
| ID: biblio-1448621
13.
Sobrevida en pacientes internados en unidades de cuidados intensivos por COVID-19 en la provincia de Buenos Aires, Argentina / Survival in patients admitted to intensive care units due to COVID-19 in the province of Buenos Aires, Argentina
Rev. argent. salud pública;
14 (Suplemento COVID-19), 2022;14: 1-7, 02 Febrero 2022.
Artigo
em Espanhol
| LILACS
| ID: biblio-1367409
14.
Efectos de la pandemia en muertes no COVID-19: Análisis en la provincia de Buenos Aires, Argentina, 2020 / Effects of the pandemic on non-COVID-19 deaths: analysis in the province of Buenos Aires, Argentina, 2020
Rev. argent. salud pública;
14 (Suplemento COVID-19), 2022;14: 1-6, 02 Febrero 2022.
Artigo
em Espanhol
| LILACS
| ID: biblio-1354567
15.
Effects of the pandemic on non-COVID-19 deaths: analysis in the province of Buenos Aires, Argentina, 2020 / Efectos de la pandemia en muertes no covid-19: análisis en la provincia de buenos aires, argentina, 2020
Rev. argent. salud publica;
14(supl.1): 46-46, feb. 2022. graf
Artigo
em Espanhol
|
LILACS-Express
| ID: biblio-1387617
16.
Survival in patients admitted to intensive care units due to COVID-19 in the province of Buenos Aires, Argentina / Sobrevida en pacientes internados en unidades de cuidados intensivos por covid-19 en la provincia de buenos aires, argentina
Rev. argent. salud publica;
14(supl.1): 48-48, feb. 2022. graf
Artigo
em Espanhol
|
LILACS-Express
| ID: biblio-1387619
17.
Antibody durability at 1 year after Sputnik V vaccination.
Lancet Infect Dis;
22(5): 589-590, 2022 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35305316
18.
Impact of vaccines against COVID-19 on new SARS-COV2 infections in health care workers of the Province of Buenos Aires / Impacto de vacunación covid-19 en las infecciones por sars-cov-2 en personal de salud de la provincia de buenos aires
Rev. argent. salud publica;
13(supl.1): 21-21, abr. 2021. graf
Artigo
em Espanhol
|
LILACS-Express
| ID: biblio-1340941
19.
Exceso de mortalidad por la pandemia de COVID-19 durante 2020 en la provincia de Buenos Aires, Argentina / Excess mortality associated with the COVID-19 pandemic during 2020 in the Buenos Aires province, Argentina
Rev. argent. salud publica;
13(Suplemento COVID-19): 1-9, 2021.
Artigo
em Espanhol
| LILACS
| ID: biblio-1248001
20.
Impacto de vacunación de COVID-19 en las infecciones por SARS-COV-2 en personal de salud de la provincia de Buenos Aires / Impact of vaccines against COVID-19 on new SARS-COV2 infections in health care workers of the Province of Buenos Aires
Rev. argent. salud publica;
13(Suplemento COVID-19): 1-9, 2021.
Artigo
em Espanhol
| LILACS
| ID: biblio-1284379